Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Clinical Trial ● Currently Recruiting Non-phase study NCT06308770

Fatigue in Lupus Intervention Programmes (FLIP)

Fatigue in Lupus Intervention Programmes (FLIP) — Recruiting • Non-phase study • Infectious Disease • NCT06308770.

📅 07 May 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT06308770
Start
2024-04-08
Completion
2026-09
ClinicaliQ Trial Snapshot
  • Fatigue in Lupus Intervention Programmes (FLIP) — Recruiting • Non-phase study • Infectious Disease • NCT06308770.
  • Virtual group fatigue management programme may reduce fatigue impact in lupus patients better than booklet alone.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Systemic Lupus Erythematosus (SLE) is an autoimmune rheumatic disease. Patients report that fatigue has a significant impact on their quality of life but is often not discussed in healthcare settings. Fatigue is more prevalent in SLE than other Rheumatic diseases. Management across the NHS is very variable ranging from a booklet to one to one appointments or, less often, a group intervention. Previous studies in other Rheumatic diseases have shown that a group cognitive behavioural approach can be effective in helping patients manage their fatigue. The COVID-19 pandemic changed the…

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
HIV Testing: Increasing Uptake Among People Who May Have Undiagnosed HIV (NICE PH33)
Infectious Disease · 27 Mar 2026
Offer opt-out HIV testing in emergency departments, sexual health clinics, and antenatal services to maximise identification of undiagnosed HIV cases without requiring…
View guideline →
Clinical Brief
Pregnancy vaccine reduces baby hospital admissions for RSV by 80%
Infectious Disease · BBC Health · 17 Apr 2026
Maternal RSV vaccination reduces infant hospitalisation risk by 80%, offering significant protection against severe lower respiratory tract infection in the first months…
View brief →
Guideline
Pneumonia in Adults: Diagnosis and Management (NICE CG191)
Infectious Disease · 27 Mar 2026
Use CRB65 score in primary care to stratify CAP severity (1 point each for confusion, respiratory rate ≥30, systolic BP
View guideline →
Guideline
Sepsis: Recognition, Diagnosis and Early Management (NICE NG51)
Infectious Disease · 27 Mar 2026
Use qSOFA tool (altered mental state, systolic BP ≤100 mmHg, respiratory rate ≥22) or NEWS2 score to identify suspected sepsis in adults…
View guideline →
Clinical Brief
Advice accepted on autumn 2026 COVID-19 vaccination programme
Infectious Disease · NHS England · 23 Mar 2026
The government has accepted advice from JCVI on eligibility for the autumn 2026 COVID-19 vaccination programme. This update is most useful for…
View brief →
Clinical Brief
‘I’m still haunted that he died alone’: The last voices of the Covid inquiry
Infectious Disease · BBC Health · 06 Mar 2026
Bereaved families have the final say as the Covid inquiry completes three years of public hearings. This update is most useful for…
View brief →